Pediatric vasculitis: a single center experience

Alexios Alexopoulos1, Maria Dakoutrou1, Kalliopi Stefanaki1

  • 1First Department of Pediatrics, University of Athens, Aghia Sofia Children's Hospital, Athens, Greece.

Insights

Henoch-Schönlein purpura is the most common childhood vasculitis presenting with a rash. While most pediatric skin vasculitides have a good prognosis, urticarial vasculitis warrants thorough examination due to potential severe underlying disease.

Area of Science:

  • Pediatric Rheumatology
  • Dermatology
  • Immunology

Background:

  • Limited studies exist on childhood vasculitis.
  • Vasculitic rash in children requires comprehensive epidemiological and clinical assessment.

Purpose of the Study:

  • To evaluate the epidemiology, clinical features, laboratory findings, and outcomes of pediatric vasculitic rash in Greece.
  • To identify the most prevalent types of childhood vasculitis and their characteristics.

Main Methods:

  • Retrospective data collection from 2003-2013.
  • Inclusion of children with a provisional diagnosis of skin vasculitis.
  • Standardized data collection forms used for analysis.

Main Results:

  • 95 children (mean age 5.9 years) were analyzed.
  • Henoch-Schönlein purpura (HSP) was diagnosed in 80% of cases.
  • Other diagnoses included hypersensitivity vasculitis (10.5%), urticarial vasculitis (6.3%), and acute hemorrhagic edema of infancy (3.1%).

Conclusions:

  • Henoch-Schönlein purpura is the predominant form of childhood vasculitis with rash.
  • Hypersensitivity vasculitis is more common in older children.
  • Urticarial vasculitis may indicate severe disease, necessitating careful evaluation; overall prognosis is good except for urticarial vasculitis.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
302
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
356
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
353
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
276
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
363
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
266